Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)

MLA

Robert Barouki, et al. “Patient and Public Involvement in the Benefit–risk Assessment and Decision Concerning Health Products: Position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM).” BMJ Global Health, vol. 8, no. 5, May 2023. EBSCOhost, https://doi.org/10.1136/bmjgh-2023-011966.

APA

Robert Barouki, Joël Ankri, Patrick Maison, Christiane Druml, Valérie Sautou, Eric Bellissant, Laëtitia Belgodère, Dominique Pougheon Bertrand, Marie Christine Jaulent, Vololona Rabeharisoa, Walter Janssens, Victoria Rollason, Janine Barbot, Jean Paul Vernant, Wahiba Oualikene Gonin, Henri Bastos, Éric Ezan, Didier Houssin, Maria Emilia Monteiro, … Jean-Paul Vernant. (2023). Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM). BMJ Global Health, 8(5). https://doi.org/10.1136/bmjgh-2023-011966

Chicago

Robert Barouki, Joël Ankri, Patrick Maison, Christiane Druml, Valérie Sautou, Eric Bellissant, Laëtitia Belgodère, et al. 2023. “Patient and Public Involvement in the Benefit–risk Assessment and Decision Concerning Health Products: Position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM).” BMJ Global Health 8 (5). doi:10.1136/bmjgh-2023-011966.